FLJ41047 Activators
FLJ41047 can facilitate the protein's function through various molecular pathways by inducing phosphorylation, a common post-translational modification that regulates protein activity. Forskolin, for instance, directly stimulates adenylate cyclase, which leads to an increase in intracellular cAMP levels. The rise in cAMP, in turn, activates protein kinase A (PKA), which can phosphorylate FLJ41047 if it serves as a PKA substrate. Similarly, isoproterenol, a beta-adrenergic receptor agonist, also elevates cAMP levels and subsequently activates PKA, potentially targeting FLJ41047 for activation. Another compound, Dibutyryl-cAMP, a cAMP analog, bypasses upstream receptors and directly activates PKA, again linking to the phosphorylation of FLJ41047. Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which might phosphorylate FLJ41047 directly if it is a PKC substrate or indirectly through downstream signaling cascades. Bradykinin, engaging with its receptor, activates PKC via phospholipase C-beta (PLCβ), offering another route for the phosphorylation of FLJ41047.
Ionomycin raises intracellular calcium levels, which can activate calcium-dependent kinases, such as calmodulin-dependent kinase (CaMK), that may phosphorylate FLJ41047. Vascular Endothelial Growth Factor (VEGF), through its receptor, initiates several signaling pathways, including the activation of PKC, further supporting the phosphorylation of FLJ41047. Insulin and Epidermal Growth Factor (EGF) each activate their respective tyrosine kinase receptors, triggering signaling cascades like the PI3K/Akt pathway for insulin and the MAPK/ERK pathway for EGF, both of which could lead to the phosphorylation and activation of FLJ41047. Anisomycin, as a stress-activated protein kinase (SAPK)/JNK pathway activator, represents yet another kinase signaling route to FLJ41047 activation. Retinoic acid, by modulating nuclear receptors, can influence kinase signaling pathways that may include the MAPK pathway, linking to the activation of FLJ41047. Lastly, hydrogen peroxide, as part of the cellular response to oxidative stress, can activate a variety of kinases capable of targeting FLJ41047 for phosphorylation through redox-sensitive signaling pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which potentially phosphorylates and activates FLJ41047 if it is a substrate for PKC or if PKC activation leads to downstream signaling events that activate FLJ41047. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as a calcium ionophore, raising intracellular calcium levels. Elevated calcium can activate calcium-dependent protein kinases, such as calmodulin-dependent kinase (CaMK), which could phosphorylate and thereby activate FLJ41047 if it is a substrate for CaMK or part of a pathway regulated by calcium signaling. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the insulin receptor, initiating a cascade of phosphorylation events through the PI3K/Akt signaling pathway. Akt can phosphorylate and activate a range of proteins, potentially including FLJ41047 if it is directly or indirectly associated with the PI3K/Akt pathway. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a synthetic agonist of beta-adrenergic receptors, leading to increased cAMP levels and activation of PKA. PKA activation could lead to the phosphorylation and activation of FLJ41047 if it is a substrate for PKA. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a potent activator of the stress-activated protein kinase (SAPK)/JNK pathway. JNK activation could lead to phosphorylation and activation of FLJ41047 if it is a substrate for JNK or part of a pathway regulated by JNK signaling. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog that activates PKA. PKA can then phosphorylate and activate FLJ41047 if it is a substrate for PKA or part of a pathway regulated by PKA signaling. | ||||||
Bradykinin | 58-82-2 | sc-507311 | 5 mg | $110.00 | ||
Bradykinin activates its G protein-coupled receptor, leading to PLCβ activation and subsequent PKC activation. PKC can potentially phosphorylate and activate FLJ41047 if it is a substrate for PKC or if PKC activation triggers downstream pathways that activate FLJ41047. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid activates retinoic acid receptors (RARs) which can modulate kinase signaling pathways. These pathways can include MAPK signaling, which may lead to the phosphorylation and activation of FLJ41047 if it is regulated by MAPK pathway components. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
Hydrogen peroxide is involved in oxidative stress signaling and can activate various kinases through the formation of reactive oxygen species (ROS). These kinases could phosphorylate FLJ41047, leading to its activation if FLJ41047 is sensitive to redox regulation. | ||||||